Research project
Cragg - KKLF - KKL981 - Overcoming tissue-mediated resistance of CLL to anti-CD20 monoclonal antibody therapy.
-
Lead researchers:
-
Other researchers:
-
Research funder:The Kay Kendall Leukaemia Fund
-
Status:Not active
